Abe, T.Y., et al. Iris pigment epithelial cell transplantation for degenerative retinal diseases.
Prog Retin Eye Res, 2007. 26(3): p. 302-21.
Barouch FC, Miller JW. The role of inflammation and infection in age-related macular degeneration.
Int Ophthalmol Clin. 2007 Spring;47(2):185-97.
Boekhoorn, S.S., et al. Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. Invest Ophthalmol Vis Sci, 2007. 48(3): p. 1012-7.
Cacho, I., et al., Visual acuity and fixation characteristics in age-related macular degeneration.
Optom Vis Sci, 2007. 84(6): p. 487-95.
Decanini, A., et al., Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration.
Am J Ophthalmol, 2007. 143(4): p. 607-15.
Dewan, A. Bracken, M. B. Hoh, J. Two genetic pathways for age-related macular degeneration.
Curr Opin Genet Dev, 2007. 17(3): p. 228-33.
Dinu V, Miller PL, Zhao H. Evidence for association between multiple complement pathway genes and AMD.
Genet Epidemiol. 2007 Apr;31(3):224-37.
Drobek-Slowik, M., D. Karczewicz, and K. Safranow The potential role of oxidative stress in the pathogenesis of the age-related macular degeneration (AMD)
Postepy Hig Med Dosw (Online), 2007. 61: p. 28-37.
Epstein P. Trials that matter: two faces of progress in the treatment of age-related macular degeneration.
Ann Intern Med. 2007 Apr 3;146(7):532-4.
Fawcett, R. J. Osborne, N. N., Flupirtine attenuates sodium nitroprusside-induced damage to retinal photoreceptors, in situ.
Brain Res Bull, 2007. 73(4-6): p. 278-88.
Fernando AN, et al. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin.
J Mol Biol. 2007 Apr 27;368(2):564-81.
Fisher SA, et al. Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD).
Hum Mutat. 2007 Apr;28(4):406-13.
Fisher SA, et al. Assessment of the contribution of CFH and chromosome 10q26 AMD susceptibility loci in a Russian population isolate.
Br J Ophthalmol. 2007 May;91(5):576-8.
Gerth C, et al. Visualization of lipofuscin accumulation in Stargardt macular dystrophy by high-resolution Fourier-domain optical coherence tomography.
Arch Ophthalmol. 2007 Apr;125(4):575.
Gibran, S.K.S., et al. Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin).
Br J Ophthalmol, 2007. 91(5): p. 602-4.
Halabe Bucay, A. Application of Pegaptanib on spinal cord lesions and central nervous system lesions to induce neuronal regeneration.
Med Hypotheses, 2007.
Huang, J.D.P. et al. Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch.
Exp Eye Res, 2007.
Izumi-Nagai, K., et al., Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization.
Am J Pathol, 2007. 170(6): p. 2149-58.
Jonas, J. B. Neumaier, M. Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema.
Ophthalmic Res, 2007. 39(3): p. 139-42.
Joussen, A.M., et al., Is significant relevant? Validity and patient benefit of randomized controlled clinical trials on age-related macular degeneration.
Surv Ophthalmol, 2007. 52(3): p. 266-78.
Joussen, A.M., Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept.
Dtsch Med Wochenschr, 2007. 132(23): p. 1268-72.
Kamei M, et al. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration.
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1801-7.
Kang, S.J., et al., Histopathologic Findings in Postmortem Eyes after Photodynamic Therapy for Choroidal Neovascularization in Age-related Macular Degeneration: Report of Two Cases.
Br J Ophthalmol, 2007.
Li, C.M., et al., Distribution and composition of esterified and unesterified cholesterol in extra-macular drusen.
Exp Eye Res, 2007
Mac Gabhann, F., et al., Protein transport to choroid and retina following periocular injection: theoretical and experimental study.
Ann Biomed Eng, 2007. 35(4): p. 615-30.
Michelson, G., et al. Morphometric age-related evaluation of small retinal vessels by scanning laser Doppler flowmetry: determination of a vessel wall index.
Retina, 2007. 27(4): p. 490-8
Morris, B.I., F. Armbrecht, A. M. Dhillon, B., Age-related macular degeneration and recent developments: new hope for old eyes? Postgrad Med J, 2007. 83(979): p. 301-7.
Mori, K., et al., Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population.
J Hum Genet, 2007. 52(7): p. 636-41.
Mullins, R.F., et al. Fibulin-5 distribution in human eyes: relevance to age-related macular degeneration. Exp Eye Res, 2007. 84(2): p. 378-80.
Narayanan, R., et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration. Ophthalmology, 2007.
Paquet-Durand, F., L. Johnson, and P. Ekstrom, Calpain activity in retinal degeneration. J Neurosci Res, 2007. 85(4): p. 693-702.
Peterson LJ, Wittchen ES, Geisen P, Burridge K, Hartnett ME. Heterotypic RPE-choroidal endothelial cell contact increases choroida endothelial cell transmigration via PI 3-kinase and Rac1.
Exp Eye Res. 2007 Apr;84(4):737-44.
Ross, R.J., et al. The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci, 2007. 48(3): p. 1128-32.
Sarks, S., et al. Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci, 2007. 48(3): p. 968-77
Schaumberg, D.A., et al. High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol, 2007. 125(3): p. 300-5.
Seddon, J.M., et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.
Jama, 2007. 297(16): p. 1793-800
Singh, A. and J.M. Stewart AMD: Should we screen? Eye, 2007. 21(2): p. 302-3.
Singh, R. and P.K. Kaiser Advances in AMD imaging. Int Ophthalmol Clin, 2007. 47(1): p. 65-74.
Sivaprasad, S., et al. Estimation of systemic complement c3 activity in age-related macular degeneration. Arch Ophthalmol, 2007. 125(4): p. 515-9.
Sjoberg AP, et al. The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells.
J Biol Chem. 2007 Apr 13;282(15):10894-900.
Soubrane, G., Actualités sur la DMLA - Editorial J Fr Ophtalmol, 2007. 30 (hors série): p. 1S3-4.
Souied, E., et al., Toward prevention of age-related macular degeneration.
J Fr Ophtalmol, 2007. 30(5): p. 449-55.
Spencer, K.L., et al., Protective Effect of Complement Factor B and Complement Component 2 Variants in Age-related Macular Degeneration.
Hum Mol Genet, 2007.
S. Stern, J. H.,et al. Human retinal pigment epithelium cell changes and expression of alphaB-crystallin: a biomarker for retinal pigment epithelium cell change in age-related macular degeneration.
Arch Ophthalmol, 2007. 125(5): p. 641-5.
Sullivan, R.K.W., E. Pow, D. V., Dendritic and synaptic plasticity of neurons in the human age-related macular degeneration retina.
Invest Ophthalmol Vis Sci, 2007. 48(6): p. 2782-91.
Tamer, C., H. Oksuz, and S. Sogut Serum dehydroepiandrosterone sulphate level in age-related macular degeneration. Am J Ophthalmol, 2007. 143(2): p. 212-216.
Tatar, O., et al. Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes. Br J Ophthalmol, 2007. 91(2): p. 166-73.
Tatar, O., et al., Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.
Br J Ophthalmol, 2007.
Thomas, G.G., et al. IDOCS: intelligent distributed ontology consensus system--the use of machine learning in retinal drusen phenotyping.
Invest Ophthalmol Vis Sci, 2007. 48(5): p. 2278-84.
Thompson, C.L., et al., Complement Factor H and Hemicentin-1 in Age-Related Macular Degeneration and Renal Phenotypes.
Hum Mol Genet, 2007
Warburton, S., et al. Proteomic and phototoxic characterization of melanolipofuscin: correlation to disease and model for its origin.
Mol Vis, 2007. 13: p. 318-29.
Wegscheider, B.J., et al. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.
Ophthalmology, 2007. 114(4): p. 738-42
Wu, K.H.T., et al. Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study.
Invest Ophthalmol Vis Sci, 2007. 48(5): p. 1983-8.
Yoshida T, et al. HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration.
Mol Vis. 2007 Apr 4;13:545-8.
Yu, J., et al., Biochemical Analysis of a Common Human Polymorphism Associated with Age-Related Macular Degeneration.
Biochemistry, 2007.
Zarbin, M.A. Functionalizing cell-based therapy for age-related macular degeneration.
Am J Ophthalmol, 2007. 143(4): p. 681-2.
Zhao, L., et al., Translocation of the retinal pigment epithelium and formation of sub-retinal pigment epithelium deposit induced by subretinal deposit.
Mol Vis, 2007. 13: p. 873-80.
Zheng, G., et al., Testing association for markers on the X chromosome.
Genet Epidemiol, 2007.
